Dogwood Therapeutics DWTX Total Stockholders' Equity Before Treasury Stock
Total Stockholders' Equity Before Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquityBeforeTreasuryStock.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total stockholders' equity before treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total stockholders' equity before treasury stock?
- Dogwood Therapeutics (DWTX) reported total stockholders' equity before treasury stock of $80.92M in Q1 2026.
- How has Dogwood Therapeutics's total stockholders' equity before treasury stock changed year-over-year?
- Dogwood Therapeutics's total stockholders' equity before treasury stock increased by 995.6% year-over-year, from $7.39M to $80.92M.
- What is the long-term trend for Dogwood Therapeutics's total stockholders' equity before treasury stock?
- Over 3 years (2022 to 2025), Dogwood Therapeutics's total stockholders' equity before treasury stock has grown at a 117.3% compound annual growth rate (CAGR), from $7.33M to $75.2M.
- What does total stockholders' equity before treasury stock mean?
- This represents the total book value of equity attributable to shareholders prior to the deduction of the cost of treasury shares held by the company. It provides a comprehensive view of the total capital contributed by shareholders and retained earnings generated by the business. This metric is essential for evaluating the company's total capitalization and the underlying value of shareholder interests before accounting for share repurchase activity.